By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Head Office
Technologielaan 3
Leuven    B - 3001  Belgium
Phone: 32-16-39-60-60 Fax: 32-16-39-60-70



Company News
TiGenix : Convening Notice To The Extraordinary Shareholders' Meeting To Be Held On 12 August 2014 7/10/2014 6:05:09 AM
TiGenix Release: European Medicines Agency Renews Marketing Authorization For Chondrocelect 7/1/2014 9:09:56 AM
TiGenix Announces The Clinical Development Of Cx611 In Early Rheumatoid Arthritis And Severe Sepsis 6/30/2014 8:03:41 AM
TiGenix Completes The Sale Of Its Dutch Manufacturing Facility To PharmaCell BV 6/2/2014 9:53:08 AM
TiGenix : Licenses Exclusive Marketing And Distribution Rights For Chondrocelect To Swedish Orphan Biovitrum 4/3/2014 8:13:40 AM
TiGenix : Full Year 2013 Financial Results 3/11/2014 9:00:57 AM
TiGenix Reaches Major Cell Therapy Milestone With 1000th Implant Of Chondrocelect 2/4/2014 9:23:32 AM
PharmaCell BV To Purchase Cell Therapy Production Facility From TiGenix 1/24/2014 9:28:37 AM
TiGenix Secures EUR 10 Million In Financing From Kreos Capital 12/23/2013 9:16:16 AM
TiGenix: Appoints Gri-Cel CEO Dirk Buscher And COO Jose Terencio To Board Of Directors Following Strategic Investment By Grifols 12/5/2013 9:36:31 AM